已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC

医学 内科学 队列 肿瘤科 生物标志物 比例危险模型 肺癌 癌症 酪氨酸激酶抑制剂 逻辑回归 生物 生物化学
作者
Hou‐Qun Ying,Yu‐Cui Liao,Yan-Ran Luo,Gang Xiong,Ying Huang,Ruo-Wei Nie,Cui-Fen Xiong,Xuexin Chen
出处
期刊:Pharmacological Research [Elsevier BV]
卷期号:170: 105734-105734 被引量:9
标识
DOI:10.1016/j.phrs.2021.105734
摘要

Cancer elicited inflammation is the main environmental cause leading to carcinogenesis and metastasis of non-small cell lung cancer (NSCLC). Roles of the inflammatory biomarker in predicting the clinical efficacy of tyrosine kinase inhibitor (TKI) and prognosis of naive patients with advanced NSCLC need to be determined, and the best inflammatory predicted biomarker remains unknown.A total of 178 eligible advanced NSCLC patients (124 and 54 cases within discovery and validation cohorts, respectively) who received first-line EGFR-TKI between July of 2014 and October of 2020 were enrolled in the present study. We detected circulating immune cell counting, albumin (Alb), pre-albumin (pAlb), ALP, AST, LDH, GGT, HDL-c, and fibrinogen (Fib) concentrations, and calculated 22 inflammatory ratios and scores. Logistic regression and Cox proportional hazards models were used to assess the impact of these ratios and scores on objective response and disease control rate (ORR and DCR) as well as progression-free survival (PFS) in these patients.Twenty-five percentage and 24.07% of NSCLC patients were observed objective response to the treatment of first-line EGFR-TKI in discovery and validation cohort, respectively. Univariate and multivariate Cox regression showed that high PLR, NPS, SII, SIS, mSIS, GLR and FPR as well as low PNI were significantly associated with poor PFS in discovery cohort. However, only high SII and FPR were found to be associated with unsatisfactory outcome in validation cohort. Time-dependent areas under ROC of FPR were 0.702 (0.517-0.888) in discovery cohort, and 0.767 (0.613-0.921) in validation cohort, which were extremely higher than the other biomarkers. The patients with FPR-SII combined score 2 harbored worse prognosis compared to the combined score 0 in discovery (plog-rank = 0.003, adjusted HR = 2.888, 95%CI = 1.500-5.560) and validation cohort (plog-rank = 0.001, adjusted HR = 3.769, 95%CI = 1.676-8.478) as well as overall population (plog-rank < 0.001, adjusted HR = 3.109, 95%CI = 1.878-5.147), and its time-dependent AUCs were 0.747 (0.594-0.900) and 0.815 (0.688-0.942) in the two cohorts, respectively, which were significantly higher than the single biomarker in the two cohorts. The patients with high FPR and FPR-SII score harbored worse DCR than the low patients in the two cohorts and overall population, respectively. Moreover, the similar poor survival was observed in advanced high-FPR NSCLC patients with different treatment options, however, the survival of low-FPR patients with treatment of single TKI, radiotherapy or chemotherapy or radio-chemotherapy combined TKI was good compared to the high-FPR patients with radio-chemotherapy combined TKI, and the survival differences were observed between TKI (plog-rank < 0.001) or radiotherapy combined TKI (plog-rank = 0.014) treated low-FPR patients and the high FPR patients. Additionally, FPR-SII combined score could monitor the progression of the disease in real-time, and the median month of the positive score appearance was significantly earlier than CT/MRI detection (p < 0.001 for 3 months vs. 13 months).High-grade cancer elicited inflammation could attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC. FPR-SII combined score was the best inflammatory biomarker to monitor and predict the progression of advanced NSCLC patients with treatment of TKI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
djf完成签到,获得积分10
刚刚
2秒前
HYL发布了新的文献求助10
2秒前
3秒前
tky完成签到,获得积分10
3秒前
摆烂小子完成签到,获得积分10
4秒前
外向不愁完成签到,获得积分20
4秒前
ryanfeng完成签到,获得积分0
4秒前
5秒前
土豪的新儿完成签到 ,获得积分10
5秒前
X悦发布了新的文献求助10
7秒前
外向不愁发布了新的文献求助10
8秒前
14秒前
今后应助tky采纳,获得10
15秒前
brick2024完成签到,获得积分10
16秒前
顺心的舞蹈完成签到,获得积分10
16秒前
白啦啦完成签到 ,获得积分10
18秒前
HYL完成签到,获得积分10
18秒前
隐形曼青应助DAZIDAZI02采纳,获得10
18秒前
SciGPT应助Lin2019采纳,获得30
20秒前
21秒前
852应助外向不愁采纳,获得10
22秒前
沉醉的中国钵完成签到 ,获得积分10
22秒前
雍雍完成签到 ,获得积分10
23秒前
GRG完成签到 ,获得积分10
23秒前
灰灰12138完成签到,获得积分10
23秒前
哈哈哈完成签到 ,获得积分10
23秒前
风吹而过完成签到 ,获得积分10
24秒前
小张完成签到 ,获得积分10
25秒前
完美世界应助百川采纳,获得10
26秒前
婷婷发布了新的文献求助10
26秒前
FleeToMars完成签到 ,获得积分10
26秒前
CipherSage应助X悦采纳,获得10
29秒前
30秒前
舒服的摇伽完成签到 ,获得积分10
31秒前
脆脆鲨完成签到 ,获得积分10
32秒前
婷婷完成签到,获得积分10
32秒前
hsk完成签到,获得积分10
32秒前
敏感代云完成签到,获得积分10
35秒前
Lin2019发布了新的文献求助30
36秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3965486
求助须知:如何正确求助?哪些是违规求助? 3510787
关于积分的说明 11155074
捐赠科研通 3245247
什么是DOI,文献DOI怎么找? 1792783
邀请新用户注册赠送积分活动 874096
科研通“疑难数据库(出版商)”最低求助积分说明 804171